COMMUNIQUÉS West-GlobeNewswire

Cirtec Medical Announces Appointment of New Chief Executive Officer
28/08/2025
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce [...]
Raina Biosciences Unveils Breakthrough Generative AI Platform for mRNA Therapeutics Featured in Science
28/08/2025
– GEMORNA is world’s first generative AI platform purpose-built for mRNA design and optimization, demonstrating state-of-the-art performance across diverse mRNA therapeutic applications – – GEMORNA designs optimized [...]
Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply
28/08/2025
Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis thérapeutique LONDRES et NEUMÜNSTER, 28 août 2025 ( [...]
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
28/08/2025
Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market [...]
Berry Street Adds Veteran Commercial, Product, and Clinical Nutrition Experts to Leadership Team
28/08/2025
New Chief Commercial Officer Richard Fu, Chief Product Officer Anita Khosla, and Head of Clinical Nutrition Michele Rager Bring Decades of Experience to Accelerate Berry Street’s Transformation in Nutrition Care NEW [...]
Tectonic Therapeutic to Participate in September Investor Conferences
28/08/2025
WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic , Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
28/08/2025
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry
28/08/2025
Highlighting multibillion-dollar drug discoveries and advancing novel oncology and immunotherapy assets AGOURA HILLS, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“OTLC” or the “ [...]
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy
28/08/2025
Compared to in-person physical therapy, claims data revealed lower healthcare utilization and spending for patients who used Omada’s programs for musculoskeletal conditions SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE [...]
Codexis to Participate in Cantor Global Healthcare Conference
28/08/2025
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the [...]
Clever Care Opens Flagship Community Center in Rowland Heights
28/08/2025
New center will bring together Eastern medicine, wellness classes, and community events to serve local Chinese, Korean, and Vietnamese plan members HUNTINGTON BEACH, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Clever Care [...]
SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc
28/08/2025
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]
Where’s the Commitment? Provincial Silence on Big Tobacco Payouts Leaves Canadians Wondering if Lung Health Will be Left Behind, Says National Lung Health Alliance
28/08/2025
NLHA: “For decades, lung health charities have shouldered the responsibility of caring for Canadians with tobacco-related disease” TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- On Friday, August 29, the provinces and [...]
Urgent Appeal: Freeze CERN Funding, Fund Innovations Suppressed for 32 Years That Can Save Millions of Lives and Billions of Euros
28/08/2025
32 Years of Suppression and Plagiarism of a Recognized Breakthrough: It is Time for Scientists and Leaders with Integrity to Endorse Funding the Inventor and Unlock the Full Potential for Cost-Effective Advances in [...]
Zealand Pharma to participate in upcoming investor conferences in September 2025
28/08/2025
Press release – No. 12 / 2025 Zealand Pharma to participate in upcoming investor conferences in September 2025 Copenhagen, Denmark, August 28, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
DeLorean AI’s Renal Platform Reduces Hospitalizations by 18 Percent, Points to Billions in Potential U.S. Savings
28/08/2025
New white paper shows real-world AI deployment helped dialysis clinics improve adherence, prevent hospital stays, and unlock scalable cost savings MIAMI, Aug. 28, 2025 (GLOBE NEWSWIRE) -- A new white paper from DeLorean [...]
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
28/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
28/08/2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to [...]
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
28/08/2025
MIAMI, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, [...]

Pages